Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Sulfa	O
(Sulfonamide	O
Antibiotics)	O
/	O
Keflex	O
/	O
Cephalosporins	O
/	O
Celebrex	O
/	O
Codeine	O
Attending:	O
___.	O
Chief	O
Complaint:	O
transfer	O
for	O
catheterization,	O
positive	O
stress	O
test	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
coronary	O
catheterization	O
___	O
with	O
DES	O
to	O
LMCA	O
History	O
of	O
Present	O
Illness:	O
Mr.	O
___	O
is	O
an	O
___	O
year	O
old	O
man	O
with	O
a	O
history	O
of	O
CAD	O
s/p	O
CABG	O
in	O
___	O
(LIMA	O
to	O
LAD,	O
SVG	O
to	O
Diag,	O
SVG	O
to	O
OM,	O
SVG	O
to	O
RCA),	O
HTN,	O
HLD,	O
CKD	O
stage	O
III,	O
cervical	O
stenosis,	O
depression,	O
BPH,	O
and	O
arthritis	O
who	O
is	O
being	O
transferred	O
from	O
___	O
to	O
undergo	O
catheterization	O
for	O
a	O
positive	O
stress	O
test	O
result.	O
.	O
He	O
was	O
admitted	O
to	O
___	O
on	O
___	O
with	O
congestive	O
heart	O
failure,	O
noting	O
___	O
weeks	O
of	O
PND,	O
orthopnea,	O
dyspnea	O
on	O
exertion,	O
and	O
a	O
five	O
pound	O
weight	O
gain.	O
He	O
had	O
intermittent	O
symptoms	O
of	O
substernal	O
heaviness	O
during	O
these	O
episodes.	O
He	O
subsequently	O
presented	O
to	O
___,	O
and	O
was	O
diuresed.	O
He	O
had	O
a	O
troponinT	O
peak	O
of	O
0.49	O
and	O
later	O
underwent	O
a	O
pharmacologic	O
nuclear	O
stress	O
suggested	O
significant	O
anterolateral	O
ischemia.	O
He	O
was	O
treated	O
with	O
aspirin,	O
plavix,	O
subQ	O
lovenox	O
before	O
and	O
transferred	O
here.	O
.	O
Of	O
note,	O
his	O
last	O
catheterization	O
was	O
here	O
at	O
___	O
in	O
___	O
due	O
to	O
CHF,	O
which	O
showed	O
patent	O
LIMA	O
and	O
SVG	O
to	O
diagonal	O
grafts	O
but	O
total	O
occlusion	O
of	O
SVG	O
to	O
PDA	O
and	O
SVG	O
to	O
OM.	O
As	O
he	O
was	O
felt	O
to	O
be	O
a	O
poor	O
re-operative	O
candidate,	O
medical	O
management	O
was	O
continued.	O
.	O
He	O
was	O
directly	O
brought	O
to	O
the	O
catheterization	O
lab,	O
where	O
he	O
underwent	O
PCI	O
yielding	O
significant	O
LMCA	O
stenosis	O
that	O
was	O
stented	O
with	O
DES,	O
as	O
well	O
as	O
diffuse	O
RCA	O
disease	O
that	O
will	O
be	O
intervened	O
upon	O
at	O
a	O
later	O
date.	O
.	O
On	O
transfer	O
to	O
the	O
cardiology	O
floor,	O
his	O
initial	O
vitals	O
were	O
T:96.9	O
BP:	O
105/55	O
P:	O
68	O
RR:18	O
___.	O
He	O
denies	O
ongoing	O
chest	O
pain	O
or	O
pressure.	O
His	O
nighttime	O
orthopnea	O
and	O
PND	O
have	O
completely	O
resolved.	O
He	O
tolerated	O
his	O
procedure	O
well.	O
On	O
review	O
of	O
systems,	O
he	O
denies	O
fevers,	O
chills,	O
cough,	O
headache,	O
nausea,	O
vomiting,	O
diarrhea,	O
abdominal	O
pain,	O
fatigue,	O
weakness,	O
dysuria,	O
hematuria,	O
syncope,	O
presyncope,	O
claudication.	O
Past	O
Medical	O
History:	O
1.	O
CARDIAC	O
RISK	O
FACTORS:	O
Dyslipidemia,	O
Hypertension	O
2.	O
CARDIAC	O
HISTORY:	O
-CABG:	O
___	O
(LIMA	O
to	O
LAD,	O
SVG	O
to	O
Diag,	O
SVG	O
to	O
OM,	O
SVG	O
to	O
RCA)	O
-PERCUTANEOUS	O
CORONARY	O
INTERVENTIONS:	O
___	O
patent	O
LIMA	O
and	O
SVG	O
to	O
diagonal	O
grafts,	O
total	O
occlusion	O
of	O
SVG	O
to	O
PDA	O
and	O
SVG	O
to	O
OM.	O
-PACING/ICD:	O
3.	O
OTHER	O
PAST	O
MEDICAL	O
HISTORY:	O
-CKD	O
-hypertension	O
-secondary	O
hyperparathyroidism	O
-hyperlipidemia	O
-hyperkalemia	O
-spinal	O
stenosis	O
-arthritis	O
-Prior	O
spine	O
surgery	O
-depression	O
-nystagmus	O
-BPH	O
-unsteady	O
gait	O
-cervical	O
spine	O
surgery	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
died	O
in	O
his	O
___	O
of	O
CVA.	O
Brother	O
died	O
___	O
MI.	O
Physical	O
Exam:	O
Admission	O
Exam:	O
VS:	O
T:96.9	O
BP:	O
105/55	O
P:	O
68	O
RR:18	O
___.	O
GENERAL:	O
Well	O
appearing	O
in	O
NAD	O
HEENT:	O
PERRLA,	O
EOMI,	O
MMM,	O
OP	O
clear	O
NECK:	O
Supple	O
without	O
JVD	O
CARDIAC:	O
RRR	O
normal	O
S1	O
S2	O
no	O
MRG.	O
PMI	O
nondisplaced.	O
LUNGS:	O
Clear	O
to	O
auscultation	O
bilaterally,	O
no	O
rales,	O
rhonchi,	O
or	O
wheezing.	O
Breathing	O
comfortably.	O
ABDOMEN:	O
Soft,	O
NTND.	O
No	O
HSM	O
or	O
tenderness.	O
Abd	O
aorta	O
not	O
enlarged	O
by	O
palpation.	O
No	O
abdominal	O
bruits.	O
EXTREMITIES:	O
trace	O
pitting	O
edema	O
to	O
the	O
ankle	O
bilaterally.	O
Weak	O
pulses	O
bilaterally.	O
SKIN:	O
No	O
stasis	O
dermatitis,	O
ulcers,	O
scars,	O
or	O
xanthomas.	O
PULSES:	O
Right:	O
Carotid	O
2+	O
Femoral	O
2+	O
Popliteal	O
2+	O
___	O
1+	O
Left:	O
Carotid	O
2+	O
Femoral	O
2+	O
Popliteal	O
2+	O
___	O
1+	O
Discharge	O
Exam:	O
VS	O
97.8	O
115/47	O
65	O
18	O
95%RA	O
69.3kg	O
GENERAL:	O
well	O
appearing	O
HEENT:	O
OP	O
clear,	O
left	O
eye	O
discharge	O
with	O
crusting	O
on	O
eyelids	O
NECK:	O
no	O
JVD	O
PULM:	O
bibasilar	O
crackle	O
CARDS:	O
RRR	O
normal	O
S1	O
S2	O
no	O
MRG	O
ABD:	O
soft,	O
NTND,	O
+BS	O
EXT:	O
WWP,	O
2+	O
DP	O
___	O
pulses.	O
LEft	O
radial	O
cath	O
access	O
point	O
C/D/I.	O
Intact	O
radial	O
pulse	O
with	O
good	O
cap	O
refill.	O
Pertinent	O
Results:	O
Admission	O
Labs:	O
From	O
OSH:	O
NA	O
141	O
K	O
4.6	O
BUN	O
28	O
CR	O
1.4	O
INR	O
1.25	O
WBC	O
11.9	O
HCT	O
42.8	O
PLT	O
316	O
BNP:861	O
Trop	O
I:	O
0.06,0.34,0.49,0.33	O
Discharge	O
Labs:	O
___	O
06:50AM	O
BLOOD	O
WBC-11.6*	O
RBC-4.14*	O
Hgb-13.9*	O
Hct-40.2	O
MCV-97	O
MCH-33.4*	O
MCHC-34.5	O
RDW-13.8	O
Plt	O
___	O
___	O
06:50AM	O
BLOOD	O
___	O
PTT-28.9	O
___	O
___	O
06:50AM	O
BLOOD	O
Glucose-75	O
UreaN-27*	O
Creat-1.5*	O
Na-141	O
K-4.5	O
Cl-106	O
HCO3-29	O
AnGap-11	O
Notable	O
Labs:	O
___	O
06:50AM	O
BLOOD	O
Calcium-9.9	O
Phos-3.3	O
Mg-2.3	O
Cholest-93	O
___	O
06:50AM	O
BLOOD	O
Triglyc-50	O
HDL-40	O
CHOL/HD-2.3	O
LDLcalc-43	O
___	O
03:04AM	O
BLOOD	O
CK-MB-4	O
___	O
06:50AM	O
BLOOD	O
CK-MB-4	O
cTropnT-0.05*	O
___	O
06:50AM	O
BLOOD	O
CK(CPK)-65	O
EKG	O
___:	O
Sinus	O
rhythm	O
with	O
first	O
degree	O
atrio-ventricular	O
conduction	O
delay.	O
Left	O
ventricular	O
hypertrophy.	O
Left	O
axis	O
deviation.	O
Non-specific	O
QRS	O
widening.	O
Compared	O
to	O
the	O
previous	O
tracing	O
of	O
___	O
multiple	O
abnormalities	O
as	O
noted	O
persist	O
without	O
major	O
change.	O
EKG	O
___:	O
Sinus	O
rhythm.	O
Compared	O
to	O
the	O
previous	O
tracing	O
multiple	O
abnormalities	O
as	O
previously	O
noted	O
persist	O
without	O
major	O
change.	O
CARDIAC	O
CATHETERIZATION	O
___:	O
(preliminary)	O
1.	O
Coronary	O
angiography	O
in	O
this	O
right	O
dominant	O
system	O
demonstrated	O
3	O
vessel	O
disease.	O
The	O
___	O
had	O
80%	O
mid	O
stenosis.	O
The	O
LAD	O
had	O
100%	O
occlusion	O
in	O
the	O
mid	O
vessel.	O
The	O
LCx	O
had	O
70%	O
origin	O
stenosis.	O
The	O
RCA	O
had	O
70-80%	O
proximal	O
stenosis	O
prior	O
to	O
large	O
RCA	O
cascade.	O
2.	O
Arterial	O
conduit	O
angiography	O
demonstrated	O
a	O
patent	O
LIMA-LAD	O
with	O
50-70%	O
stenoses	O
throughout	O
the	O
entire	O
LAD	O
and	O
a	O
100%	O
occluded	O
diagonal	O
branch	O
that	O
filled	O
via	O
left-to-left	O
collaterals.	O
The	O
SVG-diagonal,	O
SVG-OM,	O
and	O
SVG-RCA	O
were	O
all	O
occluded.	O
3.	O
Limited	O
resting	O
hemodynamics	O
revealed	O
systemic	O
arterial	O
normotension.	O
FINAL	O
DIAGNOSIS:	O
1.	O
Three	O
vessel	O
coronary	O
artery	O
disease.	O
2.	O
Patent	O
LIMA-LAD;	O
occluded	O
SVGs	O
to	O
the	O
OM,	O
diagonal	O
(new),	O
and	O
RCA.	O
Brief	O
Hospital	O
Course:	O
Mr.	O
___	O
is	O
an	O
___	O
with	O
a	O
history	O
of	O
CAD	O
s/p	O
CABG,	O
CHF,	O
HTN,	O
HLD,	O
and	O
CKD	O
who	O
was	O
transferred	O
to	O
___	O
for	O
management	O
of	O
NSTEMI	O
and	O
received	O
a	O
DES	O
to	O
his	O
___.	O
ACTIVE	O
PROBLEMS:	O
1.	O
CAD/NSTEMI:	O
He	O
has	O
an	O
extensive	O
history	O
of	O
CAD	O
with	O
a	O
CABG	O
in	O
___,	O
and	O
underwent	O
a	O
cardiac	O
catheterization	O
in	O
___	O
showing	O
occluded	O
SVG	O
to	O
OM	O
and	O
PDA.	O
He	O
presented	O
to	O
___	O
with	O
CHF,	O
and	O
was	O
found	O
to	O
have	O
an	O
elevated	O
troponin	O
consistent	O
with	O
NSTEMI.	O
His	O
EKG	O
was	O
unchanged	O
from	O
___,	O
though	O
ST-T	O
wave	O
changes	O
may	O
be	O
obscured	O
by	O
LVH.	O
He	O
later	O
underwent	O
a	O
pharmacologic	O
MIBI	O
showing	O
a	O
large	O
anterolateral	O
defect,	O
for	O
which	O
he	O
was	O
transferred	O
to	O
___	O
for	O
further	O
management.	O
His	O
catheterization	O
demonstrated	O
an	O
80%	O
LMCA	O
stenosis	O
which	O
was	O
stented	O
with	O
DES,	O
along	O
with	O
a	O
70-80%	O
proximal	O
RCA	O
stenosis	O
prior	O
to	O
large	O
RCA	O
cascade	O
that	O
was	O
not	O
intervened	O
upon.	O
He	O
was	O
chest	O
pain	O
free	O
prior	O
too	O
and	O
following	O
the	O
procedure.	O
His	O
post-procedure	O
cardiac	O
enzymes	O
showed	O
normal	O
CK	O
and	O
MB	O
with	O
a	O
weakly	O
positive	O
troponin	O
consistent	O
with	O
his	O
recent	O
NSTEMI.	O
Should	O
his	O
symptoms	O
recur,	O
he	O
may	O
need	O
to	O
return	O
for	O
cardiac	O
catheterization	O
to	O
address	O
his	O
RCA	O
disease,	O
as	O
the	O
dye	O
load	O
was	O
felt	O
to	O
be	O
too	O
great	O
to	O
address	O
both	O
vessels	O
in	O
one	O
procedure,	O
given	O
his	O
chronic	O
kidney	O
disease.	O
He	O
was	O
discharged	O
on	O
a	O
medical	O
regimen	O
including	O
aspirin,	O
plavix,	O
carvedilol,	O
atorvastatin,	O
imdur.	O
He	O
was	O
not	O
on	O
an	O
ACE,	O
presumably	O
due	O
to	O
his	O
CKD	O
and	O
hyperkalemia.	O
2.	O
CHRONIC	O
CONGESTIVE	O
HEART	O
FAILURE:	O
He	O
has	O
systolic	O
dysfunction	O
with	O
an	O
estimated	O
EF	O
of	O
___	O
based	O
on	O
a	O
___	O
TTE.	O
While	O
he	O
presented	O
to	O
___	O
with	O
acute	O
heart	O
failure,	O
he	O
was	O
euvolemic	O
on	O
admission	O
to	O
___.	O
His	O
home	O
lasix	O
dose	O
was	O
increased	O
to	O
20mg	O
daily,	O
and	O
he	O
was	O
discharged	O
with	O
instructions	O
to	O
have	O
electrolytes	O
checked	O
several	O
days	O
later.	O
3.	O
CONJUNCTIVITIS:	O
He	O
had	O
an	O
irritated	O
left	O
eye	O
with	O
crusting	O
yellow	O
discharge.	O
He	O
was	O
treated	O
with	O
a	O
5	O
day	O
course	O
of	O
erythromycin	O
drops.	O
INACTIVE	O
PROBLEMS:	O
4.	O
HYPERTENSION:	O
His	O
carvedilol,	O
amlodipine	O
were	O
continued.	O
5.	O
CKD:	O
He	O
has	O
CKD	O
stage	O
III	O
with	O
creatinine	O
remaining	O
at	O
baseline	O
of	O
1.5.	O
He	O
is	O
on	O
daily	O
kayexalate,	O
presumably	O
due	O
to	O
hyperkalemia	O
from	O
his	O
kidney	O
disease,	O
which	O
was	O
not	O
required	O
in	O
house.	O
Continued	O
paricalcitol.	O
6.	O
HYPERLIPIDEMIA:	O
Placed	O
on	O
high	O
dose	O
atorvastatin	O
for	O
ACS.	O
7.	O
DEPRESSION:	O
Euthymic,	O
on	O
paroxetine.	O
PENDING	O
TESTS	O
AT	O
DISCHARGE:	O
final	O
cath	O
report	O
TRANSITIONAL	O
ISSUES:	O
-	O
may	O
require	O
intervention	O
on	O
right	O
coronary	O
artery	O
if	O
symptoms	O
persist	O
or	O
worsen	O
-	O
trending	O
electrolytes	O
on	O
higher	O
dose	O
lasix	O
Medications	O
on	O
Admission:	O
-	O
dutasteride	O
0.5mg	O
daily	O
-	O
plavix	O
75mg	O
daily	O
-	O
tamsulosin	O
0.4mg	O
daily	O
-	O
aspirin	O
81mg	O
daily	O
-	O
carvedilol	O
6.25	O
mg	O
BID	O
-	O
simvastatin	O
80mg	O
daily	O
-	O
kayexalate	O
15g	O
daily	O
-	O
amlodipine	O
5mg	O
daily	O
-	O
isosorbide	O
mononitrate	O
120mg	O
daily	O
-	O
famotidine	O
20mg	O
BID	O
-	O
vitamin	O
d	O
1000U	O
daily	O
-	O
paricalcitol	O
1mcg	O
daily	O
-	O
paroxetine	O
10mg	O
daily	O
-	O
furosemide	O
20mg	O
every	O
other	O
day.	O
Discharge	O
Medications:	O
1.	O
dutasteride	O
0.5	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
once	O
a	O
day.	O
2.	O
clopidogrel	O
75	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
3.	O
tamsulosin	O
0.4	O
mg	O
Capsule,	O
Ext	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Capsule,	O
Ext	O
Release	O
24	O
hr	O
PO	O
DAILY	O
(Daily).	O
4.	O
aspirin	O
325	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
DAILY	O
(Daily).	O
Disp:*30	O
Tablet,	O
Delayed	O
Release	O
(E.C.)(s)*	O
Refills:*2*	O
5.	O
carvedilol	O
6.25	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
6.	O
atorvastatin	O
80	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
Disp:*30	O
Tablet(s)*	O
Refills:*2*	O
7.	O
Kayexalate	O
Powder	O
Sig:	O
Fifteen	O
(15)	O
grams	O
PO	O
once	O
a	O
day.	O
8.	O
amlodipine	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
9.	O
isosorbide	O
mononitrate	O
120	O
mg	O
Tablet	O
Extended	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Tablet	O
Extended	O
Release	O
24	O
hr	O
PO	O
once	O
a	O
day.	O
10.	O
famotidine	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
twice	O
a	O
day.	O
11.	O
Zemplar	O
1	O
mcg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
once	O
a	O
day.	O
12.	O
paroxetine	O
HCl	O
10	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
13.	O
Lasix	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
Disp:*30	O
Tablet(s)*	O
Refills:*2*	O
14.	O
cholecalciferol	O
(vitamin	O
D3)	O
1,000	O
unit	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
15.	O
erythromycin	O
5	O
mg/gram	O
(0.5	O
%)	O
Ointment	O
Sig:	O
One	O
(1)	O
drop	O
in	O
left	O
eye	O
Ophthalmic	O
QID	O
(4	O
times	O
a	O
day)	O
for	O
5	O
days.	O
Disp:*qs	O
tube*	O
Refills:*0*	O
16.	O
Outpatient	O
Lab	O
Work	O
please	O
have	O
chem10	O
checked	O
on	O
___	O
and	O
fax	O
results	O
to	O
PCP	O
___:	O
___	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	O
Facility:	O
___	O
___:	O
Coronary	O
artery	O
disease/NSTEMI	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
You	O
were	O
transferred	O
to	O
___	O
for	O
further	O
management	O
of	O
a	O
heart	O
attack.	O
You	O
underwent	O
coronary	O
catheterization	O
and	O
received	O
a	O
stent	O
to	O
one	O
of	O
the	O
major	O
vessels	O
that	O
supplies	O
your	O
heart.	O
You	O
may	O
need	O
to	O
have	O
another	O
catheterization	O
in	O
about	O
___	O
weeks	O
to	O
fix	O
one	O
of	O
the	O
other	O
vessels,	O
which	O
could	O
not	O
be	O
completed	O
at	O
this	O
time	O
due	O
to	O
concern	O
over	O
hurting	O
your	O
kidneys.	O
The	O
following	O
changes	O
were	O
made	O
to	O
your	O
meds	O
1.	O
START	O
ATORVASTATIN	O
80mg	O
daily	O
2.	O
STOP	O
SIMVASTATIN	O
3.	O
INCREASE	O
LASIX	O
to	O
20mg	O
EVERY	O
DAY	O
4.	O
INCREASE	O
ASPIRIN	O
TO	O
325mg	O
daily	O
5.	O
START	O
ERYTHROMYCIN	O
EYE	O
DROP-	O
one	O
drop	O
to	O
left	O
eye	O
4	O
times	O
daily	O
for	O
5	O
days	O
for	O
possible	O
conjunctivitis	O
Please	O
continue	O
all	O
of	O
your	O
other	O
medications	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you,	O
Mr.	O
___	O
Followup	O
Instructions:	O
___	O

